Navigation Links
EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
Date:3/3/2008

Online feedback platform will remain open until March 21, 2008

HOUSTON, March 3 /PRNewswire-USNewswire/ -- Using the same process as government agencies when implementing new policies, a national alliance of scientists, public health leaders, and community representatives today called for public comment on a series of proposals designed to eliminate continued disparities in U.S. clinical trials.

As part of the four year initiative, Eliminating Disparities in Clinical Trials (EDICT), a project jointly conducted by Baylor College of Medicine's Chronic Disease Prevention and Control Research Center and the Intercultural Cancer Council, the alliance created a new Web-based portal so policy makers, patient advocates, research scientists and industry members can review the proposals developed to improve clinical trials patient recruitment and retention in medical research studies. The public comment period closes on March 21, 2008.

On April 1, EDICT will issue its final policy recommendations in Washington, DC.

"A variety of systemic, cultural and psychosocial barriers prevent participation by underrepresented populations, including women, adolescents, older adults, racial and ethnic minorities, those with disabilities, in rural areas and others," said Armin D. Weinberg, Ph.D., Director of Baylor College of Medicine's Chronic Disease Prevention and Control Research Center and EDICT's Principal Investigator.

More than 300 representatives of public, private and non-profit stakeholders catalogued the most significant barriers to participation, examined current policies related to clinical trials, identified opportunities for policy change that would address those barriers, and developed practical and realizable policy solutions to clinical trial disparities at the federal, state and institutional levels in the public, private and non-profit sectors.

"Our policy research has demonstrated the importance of involving the broadest possible set of stakeholders as part of this process. To date, we had input from across all stakeholder groups involved in clinical trials. We are now seeking input from the public at large. We hope that interested individuals and those representing concerned populations will review the policy change recommendations and provide feedback," Weinberg said.

To review the policy recommendations and provide feedback, go to http://www.bcm.edu/edict/policyreview.

EDICT Credo:

-- Everyone should have the opportunity and necessary support to participate voluntarily in clinical trials for which they are eligible.

-- Participants and researchers should understand the benefits of diversity in clinical trials.

-- Results from clinical research should benefit the participants' communities and society at large.

The EDICT (Eliminating Disparities in Clinical Trials) Project was created by Baylor College of Medicine's Chronic Disease Prevention and Control Research Center with the Intercultural Cancer Council and supported by an unrestricted educational grant from Genentech, Inc.


'/>"/>
SOURCE EDICT
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Simple Test Accurately Predicts Risk of Serious Jaundice in Newborns
2. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
3. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
4. DNA Test Predicts Harmful Effects of Cancer Drug
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
7. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
8. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
9. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
10. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
11. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/11/2017)...  Caris Life Sciences ® , a leading innovator ... precision medicine, today announced that St. Jude Medical Center,s ... (POA) as its 17 th member. Through participation ... Cancer Institute will help develop standards of care and ... making cancer treatment more precise and effective. ...
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):